Onconetix, Inc. (ONCO)
NASDAQ: ONCO · IEX Real-Time Price · USD
0.152
-0.001 (-0.72%)
Jun 20, 2024, 3:58 PM EDT - Market closed

Onconetix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022
Market Capitalization
3417
Market Cap Growth
--78.30%-
Enterprise Value
149-9
PE Ratio
-0.06-0.10-1.26
PS Ratio
3.8163.18-
PB Ratio
-0.13-0.660.76
P/FCF Ratio
-0.20-0.27-1.96
P/OCF Ratio
-0.20-0.27-1.96
EV/Sales Ratio
18.22154.37-
EV/EBITDA Ratio
-0.31-0.250.65
EV/EBIT Ratio
-0.31-0.250.65
EV/FCF Ratio
-0.96-0.661.01
Debt / Equity Ratio
-0.72-1.76-
Debt / EBITDA Ratio
-0.35-0.27-
Debt / FCF Ratio
-1.07-0.72-
Quick Ratio
0.220.276.57
Current Ratio
0.290.346.69
Asset Turnover
0.010.000
Interest Coverage
-41.24-54.72-
Return on Equity (ROE)
4779.80%-400.10%-63.40%
Return on Assets (ROA)
-83.00%-89.30%-54.40%
Return on Capital (ROIC)
721.95%-841.19%-60.22%
Earnings Yield
-1580.11%-1012.78%-79.40%
FCF Yield
-498.95%-369.16%-51.02%
Buyback Yield / Dilution
-39.20%-39.44%-283.48%
Total Shareholder Return
-39.20%-39.44%-283.48%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).